ANTONIO RIVERO ROMÁN2026-01-292026-01-29201710.1080/17425255.2017.12922532-s2.0-85013146761https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/27884PharmacologyToxicologyPharmacokinetic drug evaluation of velpatasvir plus sofosbuvir for the treatment of hepatitis C virus infectionresearch article